Transpulmonary Chemoembolization: A Novel Approach for the Treatment of Unresectable Lung Tumors

Techniques in Vascular and Interventional Radiology

Volumn 10, Issue 2, 2007, Pages 114-119

  Lindemayr, Sebastian ^a   Lehnert, Thomas ^a   Korkusuz, Hüdayi ^a   Hammerstingl, Renate ^a   Vogl, Thomas J ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

lung tumors; palliative treatment; pulmonary metastases; transpulmonary chemoembolization

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; DOXORUBICIN; ETHIODIZED OIL; IODINATED POPPYSEED OIL; MICROSPHERE; MITOMYCIN C; STARCH MICROSPHERE;

ARTICLE; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CATHETERIZATION; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INOPERABLE CANCER; LUNG CARCINOMA; LUNG METASTASIS; LUNG TUMOR; NONHUMAN; SYMPTOMATOLOGY; TECHNIQUE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TUMOR VOLUME; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS; CHEMOEMBOLIZATION, THERAPEUTIC; CYTOTOXINS; ETHIODIZED OIL; HUMANS; LUNG NEOPLASMS; MICROSPHERES; PALLIATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PULMONARY ARTERY;

EID: 36749079053     PISSN: 10892516     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.tvir.2007.09.010     Document Type: Article

References (46)

1. Zutic H. Bronchial carcinoma-an overview. Med Arh 53 3 suppl 1 (1999) 27-31
2. American Cancer Society. Cancer Facts & Figures 2002 (2002), American Cancer Society, Atlanta, GA
3. Weiss W., Boucot K.R., and Cooper D.A. The Philadelphia pulmonary neoplasm research project. Survival factors in bronchogenic carcinoma. JAMA 216 13 (1971) 2119-2123
4. Müller M. Chirurgie für Studium und Praxis: unter Berücksichtigung des Gegenstandskataloges und der mündlichen Examina in den ärztlichen Prüfungen 2002/03/ Markus Müller und Mitarb.-6 (2001), Med.Verl.- und Informationsdienste, Aufl.-Breisach/Rh S. 101
5. Frommhold W., and Gerhardt P. Klinisch-radiologisches Seminar, Band 17, Tumoren der Lunge (1987), Georg-Thiemeverlag Stuttgart, New York S 93
6. McCormack P. Surgical resection of pulmonary metastases. Semin Surg Oncol 6 (1990) 297-302
7. Herth F.J.F. Epidemiologie, symptomatik und diagnostik des bronchialkarzinoms. Klinikarzt 34 (2005) 202-205
8. American Cancer Society. Cancer Facts & Figures 2004 (2004), American Cancer Society, Atlanta, GA
9. Plickova K., Spidlen V., Pesek M., et al. Patient survival analysis in surgery of bronchogenic carcinoma from 1986 to 1997. Rozhl Chir 82 (2003) 293-299
10. Hendriks J.M., Grootenboers M.J., Schramel F.M., et al. Isolated lung perfusion with melphalan for resectable lung metastases: a phase I clinical trial. Ann Thorac Surg 78 (2004) 1919-1927 discussion 1919-1927
11. Vogt-Moykopf I., Bulzebruck H., Krysa S., et al. Results in surgery of pulmonary metastases. Chirurgie 118 (1992) 263-271
12. Friedel G., Pastorino U., Buyse M., et al. Resection of lung metastases: long-term results and prognostic analyses based on 5.206 cases. The International Registry of Lung Metastases. Zentralbl Chir 124 (1999) 96-103
13. Hendriks J.M., Romijn S., Van Putte B., et al. Long-term results of surgical resection of lung metastases. Acta Chir Belg 101 (2001) 267-272
14. Abecasis N., Cortez F., Bettencourt A., et al. Surgical treatment of lung metastases: prognostic factors for long-term survival. J Surg Oncol 72 (1999) 193-198
15. Lanza L.A., Putnam J.B., Benjamin R.S., et al. Response to chemotherapy does not predict survival after resection of sarcoma pulmonary metastases. Ann Thorac Surg 51 (1991) 219-224
16. Casson A.G., Putnam J.B., Natarajan G., et al. Five year survival after pulmonary metastasectomy for adult soft-tissue sarcoma. Cancer 69 (1992) 662-668
17. Ueda T., Uchida A., Kadama K., et al. Aggressive pulmonary metastasectomy for soft tissue sarcoma. Cancer 72 (1993) 1919-1925
18. Weksler B., Ng B., Lenert J.T., et al. Isolated single-lung perfusion with doxorubicin is pharmacokinetically superior to intravenous injection. Ann Thorac Surg 56 (1993) 209-214
19. Mentzer S.J., Antman K.H., Attinger C., et al. Selected benefits of thoracotomy and chemotherapy for sarcoma metastatic to the lung. J Surg Oncol 53 (1993) 54-59
20. Greenall M.J., Magill G.B., De Cosse J.J., et al. Chemotherapy for soft tissue sarcoma. Surg Gynecol Obstet 162 (1986) 193-198
21. Dirix L.J., and Oosterom A.T. Diagnosis and treatment of soft tissue sarcomas in adults. Curr Opin Oncol 6 (1994) 372-383
22. Van Schil P.E. Surgical treatment for pulmonary metastases. Acta Clin Belg 57 (2002) 333-339
23. Pan Y., Krueger T., and Tran N. Evaluation of tumour vascularisation in two rat sarcoma models for studying isolated lung perfusion. Injection route determines the origin of tumour vessels. Eur Surg Res 37 (2005) 92-99
24. Van Putte B.P., Hendriks J.M., Romijn S., et al. Isolated lung perfusion for the treatment of pulmonary metastases: current mini-review of work in progress. Surg Oncol 12 (2003) 187-193
25. Romijn S., Hendriks J.M., Van Putte B.P., et al. Anterograde versus retrograde isolated lung perfusion with melphalan in the WAG-Rij rat. Eur J Cardiothorac Surg 27 (2005) 1083-1085
26. Hendriks J.M., Romijn S., Van Putte B., et al. Isolated lung perfusion for the treatment of pulmonary metastatic disease: a review. Acta Chir Belg 105 (2005) 338-343
27. Muller H., and Hilger R. Curative and palliative aspects of regional chemotherapy in combination with surgery. Support Care Cancer 11 (2003) 1-10
28. Van Putte B.P., Hendriks J.M., Romijn S., et al. Single-pass isolated lung perfusion versus recirculating isolated lung perfusion with melphalan in a rat model. Ann Thorac Surg 74 (2002) 893-898 discussion 898
29. Romijin S., Hendriks J.M., Van Putte B.P., et al. Regional differences of melphalan lung levels after isolated lung perfusion in the rat. J Surg Res 125 (2005) 157-160
30. Franke U.F., Wittwer T., Lessel M., et al. Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: I. Influence of perfusion pressure and hyperthermia on functional and morphological lung integrity. Eur J Cardiothorac Surg 26 (2004) 792-799
31. Demmy T.L., Wagner-Mann C., and Allen A. Isolated lung chemotherapeutic infusions for treatment of pulmonary metastases: a pilot study. J Biomed Sci 9 (2002) 334-338
32. Burt M.E., Liu D., Abolhoda A., et al. Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trial. Ann Thorac Surg 69 (2000) 1542-1549
33. Johnston M.R., Minchin R., and Dawson C.A. Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg 110 (1995) 368-373
34. Pass H.I., Mew D.J., Kranda K.C., et al. Isolated lung perfusion with tumor necrosis factor for pulmonary metastases. Ann Thorac Surg 61 (1996) 1609-1617
35. Schneider P., Kampfer S., Loddenkemper C., et al. Chemoembolization of the lung improves tumor control in a rat model. Clin Cancer Res 8 (2002) 2463-2468
36. Ratto G.B., Toma S., Civalleri D., et al. Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas. J Thorac Cardiovasc Surg 112 (1996) 614-622
37. Vogl T.J., Trapp M., Schroeder H., et al. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology 214 (2000) 349-357
38. Miller B.J., and Rosenbaum A.S. The vascular supply to metastatic tumors of the lung. Surg Gynecol Obstet 125 (1967) 1009-1012
39. Huppert P.E., Geissler F., Duda S.H., et al. Chemoembolisation des hepatozellulären karzinoms: Computertomographische Befunde und klinische Resultate bei prospektiver repetitiver Therapie. Fortschr Roentgenstr 160 (1994) 425-432
40. Vogl T.J., Wetter A., Lindemayr S., and Zangos S. Treatment of unresectable lung metastases with transpulmonary chemoembolization: preliminary experience. Radiology 234 (2005) 917-922
41. Start of trial to evaluate drug eluting bead in lung cancer announced. http://www.newsrx.com/newsletters/Clinical-Oncology-Week/2006-03-20/03202006333205CO.html Lung Cancer, March 20th, 2006
42. Lewis A.L., Gonzalez M.V., Lloyd A.W., et al. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17 2 pt 1 (2006) 335-342
43. http://www.biocompatibles.co.uk/content.asp?pid=9 Accessed Oct. 2007
44. Mountain C.F., Khalil K.G., Hermes K.F., et al. The contribution of surgery to the management of carcinomatous pulmonary metastases. Cancer 41 (1978) 833-840
45. Inoue Y., Miki C., Hiro J., et al. Improved survival using multi-modality therapy in patients with lung metastases from colorectal cancer: a preliminary study. Oncol Rep 14 (2005) 1571-1576
46. Wagner W., von Eiff M., Klinke F., et al. [Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study]. Strahlenther Onkol 171 (1995) 390-397